- Report
- August 2023
- 77 Pages
Canada
From €2671EUR$2,975USD£2,275GBP
€3142EUR$3,500USD£2,676GBP
- Report
- August 2023
- 76 Pages
Egypt
From €2671EUR$2,975USD£2,275GBP
€3142EUR$3,500USD£2,676GBP
- Report
- August 2023
- 79 Pages
Canada
From €2671EUR$2,975USD£2,275GBP
€3142EUR$3,500USD£2,676GBP
- Report
- August 2023
- 78 Pages
Israel
From €2671EUR$2,975USD£2,275GBP
€3142EUR$3,500USD£2,676GBP
- Report
- February 2024
- 115 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- February 2024
- 96 Pages
North America
From €4265EUR$4,750USD£3,632GBP
- Report
- April 2023
- 80 Pages
South Korea
From €4265EUR$4,750USD£3,632GBP
- Drug Pipelines
- July 2022
- 60 Pages
Global
From €2020EUR$2,250USD£1,720GBP
- Report
- February 2024
- 110 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- February 2024
- 120 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- February 2024
- 132 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- February 2024
- 110 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- April 2023
- 75 Pages
Europe
From €4265EUR$4,750USD£3,632GBP
- Report
- April 2023
- 68 Pages
Canada
From €4265EUR$4,750USD£3,632GBP
- Report
- March 2024
- 200 Pages
Global
From €3726EUR$4,150USD£3,173GBP
- Report
- March 2024
- 200 Pages
Global
From €3726EUR$4,150USD£3,173GBP
- Report
- April 2023
- 150 Pages
Global
From €2918EUR$3,250USD£2,485GBP
€4355EUR$4,850USD£3,708GBP
- Report
- November 2023
- 150 Pages
Global
From €3995EUR$4,450USD£3,402GBP
- Report
- April 2022
- 217 Pages
Global
From €3995EUR$4,450USD£3,402GBP
- Report
- January 2022
- 188 Pages
Global
From €3995EUR$4,450USD£3,402GBP

The Implantable Cardioverter Defibrillator (ICD) market is a segment of the Cardiovascular Devices market. ICDs are medical devices used to treat life-threatening arrhythmias, or abnormal heart rhythms. They are implanted in the chest and monitor the heart's electrical activity. When an abnormal rhythm is detected, the device delivers an electrical shock to restore normal rhythm. ICDs are used to treat ventricular tachycardia and ventricular fibrillation, two of the most common causes of sudden cardiac death.
The ICD market is driven by the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive treatments. The market is expected to grow at a steady rate over the forecast period.
Some of the major players in the ICD market include Medtronic, Abbott, Boston Scientific, Biotronik, LivaNova, and Sorin Group. Show Less Read more